Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Popular Antibiotics Get Serious FDA Warning Label

In some cases, side effects from the drug may outweigh the benefits.

The FDA is now requiring the class of antibiotics called fluoroquinolones to have a stronger warning about side effects causing serious issues, adding that in some cases, they outweigh the benefits.

Side effects can include damage to the central nervous system, mucles, joints, nerves and tendons, according to The Wall Street Journal.

Popular brand names of such drugs include Johnson & Johnson’s Levaquin and Bayer AG’s Cipro, generically called ciprofloxacin. This class of drugs have been on the market for about three years, the news outlet reported.

According to The Wall Street Journal, "Johnson & Johnson said it is studying the FDA’s statement and noted that Levaquin has been used for more than 20 years," while, Bayer said it is "aware of the FDA statement and will work closely with the FDA on the topic."

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging